IRIS
PACINI, FURIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.403
EU - Europa 6.147
AS - Asia 1.128
SA - Sud America 127
AF - Africa 23
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14.851
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.385
GB - Regno Unito 2.151
IE - Irlanda 938
IT - Italia 710
CN - Cina 646
UA - Ucraina 561
SE - Svezia 504
RU - Federazione Russa 431
SG - Singapore 333
DE - Germania 287
FR - Francia 276
FI - Finlandia 157
BR - Brasile 108
VN - Vietnam 56
BE - Belgio 29
TR - Turchia 26
NL - Olanda 25
ES - Italia 19
IN - India 19
AT - Austria 12
AU - Australia 10
CA - Canada 10
PL - Polonia 10
EU - Europa 8
HK - Hong Kong 8
CZ - Repubblica Ceca 7
IR - Iran 7
AR - Argentina 6
CI - Costa d'Avorio 6
MA - Marocco 5
NZ - Nuova Zelanda 5
CH - Svizzera 4
CL - Cile 4
RO - Romania 4
ZA - Sudafrica 4
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
IQ - Iraq 3
MX - Messico 3
PK - Pakistan 3
UZ - Uzbekistan 3
BY - Bielorussia 2
CU - Cuba 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
KR - Corea 2
LV - Lettonia 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
EC - Ecuador 1
GE - Georgia 1
GR - Grecia 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
PH - Filippine 1
PS - Palestinian Territory 1
SN - Senegal 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 14.851
Salva come PNG Salva come JPEG
Città #
Southend 2.033
Fairfield 1.258
Dublin 919
Woodbridge 594
Chandler 587
Ashburn 578
Wilmington 475
Seattle 470
Jacksonville 450
Houston 443
Santa Clara 417
Cambridge 412
Ann Arbor 291
Siena 287
Nanjing 152
Princeton 150
Beijing 130
Singapore 130
Boardman 80
Helsinki 76
San Diego 64
Dong Ket 56
Nanchang 55
Moscow 48
San Mateo 42
Saint Petersburg 40
Council Bluffs 35
Düsseldorf 35
Milan 32
London 30
Shenyang 29
Florence 28
Shanghai 28
Brussels 27
Kunming 27
Jiaxing 26
Lancaster 26
New York 26
Tianjin 26
Hebei 24
Izmir 21
Prato 20
Dearborn 19
Los Angeles 19
Changsha 18
Norwalk 18
Redwood City 18
Washington 18
Jinan 17
Zhengzhou 16
Málaga 15
Ningbo 14
Renton 13
Rome 13
Guangzhou 12
Venezia 12
Menlo Park 9
Phoenix 9
Vienna 9
Chicago 7
Hangzhou 7
Naples 7
Palermo 7
San Francisco 7
Saronno 7
São Paulo 7
Taizhou 7
Toronto 7
Abidjan 6
Arezzo 6
Codogno 6
Melbourne 6
Munich 6
Nuremberg 6
Salerno 6
Belo Horizonte 5
Brno 5
Dallas 5
Edinburgh 5
Piscataway 5
Amsterdam 4
Curitiba 4
Frankfurt am Main 4
Hefei 4
Hong Kong 4
Lanzhou 4
Oak Park 4
Teverola 4
Auckland 3
Bari 3
Belvedere Marittimo 3
Bonndorf 3
Brescia 3
Cincinnati 3
Delhi 3
Falls Church 3
Fuzhou 3
Gliwice 3
Jinhua 3
Lamezia Terme 3
Totale 11.124
Salva come PNG Salva come JPEG
Nome #
null 398
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 250
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 241
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer 220
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 219
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 219
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 216
Reference range of serum calcitonin in pediatric population 205
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 199
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 198
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer 195
Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 year 191
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 191
Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism 188
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update 183
Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab 181
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 181
Acute exogenous TSH administration stimulates leptin secretion in vivo 180
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres 178
Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients 178
Approach to and treatment of differentiated thyroid carcinoma 176
Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB) 175
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone 171
Management of papillary thyroid microcarcinoma: primum non nocere! 170
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients 166
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 164
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer 160
Definition and management of radioactive iodine-refractory differentiated thyroid cancer 160
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up 159
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment 159
Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer 159
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 156
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 155
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. 153
Changing natural history of differentiated thyroid cancer 153
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients 153
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 151
Ernest L. Mazzaferri, MD, MACP (1936-2013) 151
Management of thyroid nodules: a clinicopathological, evidence-based approach 150
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 148
Medullary thyroid carcinoma 148
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer 147
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question 145
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 145
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 144
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa 142
Screening of thyroid nodules by serum calcitonin measurements: why not? 139
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 139
Post-thyroidectomy chronic asthenia: self-deception or disease? 138
Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thyroid cancer 137
H. pylori (hp) infection and autoimmune diseases (ad): prevalence of infection in patients with Hashimoto's thyroiditis (ht) and allignement of thyroid hormones (th) with H. pylori proteins. 136
Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients 136
Observation for newly diagnosed micro-papillary thyroid cancer: is now the time? 135
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. 134
Management of differentiated thyroid cancer of the follicular epithelium 133
Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis 132
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma 131
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? 130
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology 130
Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions 129
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 128
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. 128
Telomeres and thyroid cancer 126
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal 126
null 126
Management of advanced medullary thyroid cancer 125
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 122
Serum Ghrelin As a Marker of Atrophic Body Gastritis in Patients With Parietal Cell Antibodies 121
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study 121
Rare diseases in clinical endocrinology: a taxonomic classification system 119
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 119
Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer 119
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 119
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 118
Multinodular goiter of unusual shape and location 116
Targeted therapy in refractory thyroid cancer: current achievements and limitations 116
How Far Should We Go in the Search and Treatment of Recurrent or Persistent Lymph Node Metastases during Follow-Up of Thyroid Cancer Patients? 116
Medullary thyroid cancer: management guidelines of the American Thyroid Association 116
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 116
The low utility of pretherapy scans in thyroid cancer patients 115
Best practice & research clinical endocrinology & metabolism. Thyroid nodules and cancer. Preface 114
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 114
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer 113
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo 112
New insight in the follow-up strategies of differentiated thyroid cancer 109
Thyroid microcarcinoma 109
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 109
Down modulation of IG20/MADD expression or phosphorylation renders TRAIL resistant thyroid cancer cells susceptible to TRAIL treatment 108
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study 106
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer 103
RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration 102
Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis 101
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis 100
null 94
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 89
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 88
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 78
Radioiodine therapy in the different stages of differentiated thyroid cancer 67
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cute-off level for RET/PTC rearrangements. 64
Manuale di medicina interna 62
Totale 14.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.385
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020745 0 0 0 0 0 0 0 0 289 231 62 163
2020/20212.322 84 232 66 219 166 289 133 376 178 234 161 184
2021/20221.285 132 183 71 100 68 53 62 41 82 143 142 208
2022/20231.961 115 173 262 271 194 387 38 173 214 32 73 29
2023/20241.265 69 30 107 39 52 355 463 19 6 18 16 91
2024/20251.584 60 140 245 140 394 200 96 150 159 0 0 0
Totale 15.043